Literature DB >> 6231656

Aspirin inhibition of platelet deposition at angioplasty sites: demonstration by platelet scintigraphy.

D A Cunningham, B Kumar, B A Siegel, L A Gilula, W G Totty, M J Welch.   

Abstract

In-111 platelet scintigraphy was used to evaluate the effects of prior aspirin administration on the accumulation of In-111-labeled autologous platelets at sites of arterial injury resulting from iliac, femoral, or popliteal transluminal angioplasty in a nonrandomized study of 17 men. The degree of platelet localization at angioplasty sites was significantly less in nine men who had received aspirin in varying doses within the 4 days before angioplasty than in eight men who had not received aspirin for at least two weeks. Our results suggest that aspirin treatment before angioplasty limits the early platelet deposition at the angioplasty site in men.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6231656     DOI: 10.1148/radiology.151.2.6231656

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Late hemodynamic failure following percutaneous transluminal angioplasty for long and multifocal femoropopliteal stenoses.

Authors:  B Jørgensen; K H Tønnesen; P Holstein
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Sep-Oct       Impact factor: 2.740

2.  Percutaneous transluminal angioplasty in the treatment of lower limb ischaemia.

Authors:  M E Sugrue; M Lee; W P Hederman; D Legge
Journal:  Ir J Med Sci       Date:  1988-04       Impact factor: 1.568

Review 3.  Antiplatelet therapy--Part II.

Authors:  S H Goodnight; B M Coull; J H McAnulty; L M Taylor
Journal:  West J Med       Date:  1993-05

Review 4.  Modulating thrombotic potential in catheter-based percutaneous coronary and peripheral vascular interventions.

Authors:  James L Orford; Peter B Berger
Journal:  J Thromb Thrombolysis       Date:  2004-02       Impact factor: 2.300

Review 5.  Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features.

Authors:  J L Cox; A I Gotlieb
Journal:  CMAJ       Date:  1986-05-15       Impact factor: 8.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.